Search
for
Sort by
Research 901–930 of 1000+
- Topical 4‐Aminopyridine 5% in Male Androgenetic Alopecia: A Split‐Scalp Exploratory Series
- Beyond Minoxidil: Evidence-Based Off-Label Therapies for Male Androgenetic Alopecia
- Evaluation of Sexual Dysfunctions in Male Patients with Androgenetic Alopecia
- Immunogenetic and metabolic risk factors in male androgenetic alopecia: the role of HLA-DRB1 alleles and vitamin D3 deficiency
- Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Research on the Quality Differences between Male and Female Plants of Gynostemma longipes Based on Broad Target Metabolomics
- Follicular Mucinosis in a Young Male: A Case Report and Literature Review
- Taurine Alleviates Androgenetic Alopecia in Male C57BL/6 Mice by Modulating Hair Follicle Cycle and Related Signaling Pathways
- Prevalence of Metabolic Syndrome and Cardiovascular Risk Factors in Early Onset Male Androgenetic Alopecia - A Cross Sectional Study in a Tertiary Care Hospital
- An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications
- The postnatal offspring of finasteride-treated male rats show altered ERα and PCNA expression in the liver
- Advances in the treatment of male androgenetic alopecia: current options and emerging therapies
- Dose–Response Effects of Oral Melatonin on Reproductive Parameters in Intact Male Pomeranian Dogs With Alopecia X: A Controlled Study
- Relative efficacy of monotherapies for male pattern hair loss: protocol for a network meta-analysis study
- No increased risk of mood disorders in male androgenetic alopecia patients treated with dutasteride and finasteride: a retrospective cohort database study
- The impact of minoxidil on male reproductive biology: a multi-approach study including systematic review, in vivo, and ex vivo experiments
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Unmasking pseudopelade of Brocq in male adult: a rare case report
- The effect of chemotherapy regimens in male germ cell tumors on the development of primary hypogonadism
- Is There an Association Between Male Alopecia Areata and the Ratio of Second to Fourth Finger Length?
- From bench to babies – drug development for male subfertility
- 53289 Clinical and metabolic characteristics of male patients with early-onset androgenetic alopecia: A possible predisposition to metabolic syndrome
- Case 1: Clitoromegaly, Oligomenorrhea, and Hirsutism in a 17-year-old Transgender Male
- Efficacy of Botulinum Toxin in Male Androgenetic Alopecia: a Triple-Blind, Randomized Clinical Trial
- Correction to “Divergent progression pathways in male androgenetic alopecia and female pattern hair loss: Trichoscopic perspectives”
- A pharmacovigilance study of drug‐reduced male semen quality based on the Food and Drug Administration adverse event reporting system database
- Predictability of Insulin Resistance Based on the Clinical Manifestations Among Male Medical Students of a Private College in Saudi Arabia
- Risk factors and lipid metabolism characteristics of early‐onset male androgenetic alopecia: A pilot study